Acutus Medical (NASDAQ:AFIB) and NEXGEL (NASDAQ:NXGL) Financial Review

Profitability

This table compares NEXGEL and Acutus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NEXGEL	-52.60%	-71.19%	-34.79%
Acutus Medical	-272.74%	-311.64%	-11.57%

Valuation & Earnings

This table compares NEXGEL and Acutus Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NEXGEL	$6.73 million	4.75	-$3.16 million	($0.58)	-8.12
Acutus Medical	$7.16 million	0.27	-$81.66 million	N/A	N/A

NEXGEL has higher earnings, but lower revenue than Acutus Medical.

Institutional & Insider Ownership

2.2% of NEXGEL shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 24.9% of NEXGEL shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Volatility and Risk

NEXGEL has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.22, meaning that its share price is 122% less volatile than the S&P 500.

Summary

NEXGEL beats Acutus Medical on 6 of the 9 factors compared between the two stocks.

About NEXGEL

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.